JPH10512590A5 - - Google Patents

Info

Publication number
JPH10512590A5
JPH10512590A5 JP1997517176A JP51717697A JPH10512590A5 JP H10512590 A5 JPH10512590 A5 JP H10512590A5 JP 1997517176 A JP1997517176 A JP 1997517176A JP 51717697 A JP51717697 A JP 51717697A JP H10512590 A5 JPH10512590 A5 JP H10512590A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997517176A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10512590A (ja
JP4531865B2 (ja
Filing date
Publication date
Priority claimed from HU9503141A external-priority patent/HU222994B1/hu
Application filed filed Critical
Publication of JPH10512590A publication Critical patent/JPH10512590A/ja
Publication of JPH10512590A5 publication Critical patent/JPH10512590A5/ja
Application granted granted Critical
Publication of JP4531865B2 publication Critical patent/JP4531865B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP51717697A 1995-11-02 1996-11-01 分子シャペロン産生を増強するのに有用なヒドロキシルアミン誘導体およびそれの調製 Expired - Fee Related JP4531865B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
HU9503141 1995-11-02
HU9503141A HU222994B1 (hu) 1995-11-02 1995-11-02 Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HU9603919 1996-02-09
HU9503141/3919 1996-02-09
HU9503141/29820 1996-10-04
HU9629820 1996-10-04
PCT/HU1996/000064 WO1997016439A1 (en) 1995-11-02 1996-11-01 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008261964A Division JP2009108048A (ja) 1995-11-02 2008-10-08 分子シャペロン産生を増強するのに有用なヒドロキシルアミン誘導体およびそれの調製

Publications (3)

Publication Number Publication Date
JPH10512590A JPH10512590A (ja) 1998-12-02
JPH10512590A5 true JPH10512590A5 (enExample) 2004-10-21
JP4531865B2 JP4531865B2 (ja) 2010-08-25

Family

ID=27270113

Family Applications (2)

Application Number Title Priority Date Filing Date
JP51717697A Expired - Fee Related JP4531865B2 (ja) 1995-11-02 1996-11-01 分子シャペロン産生を増強するのに有用なヒドロキシルアミン誘導体およびそれの調製
JP2008261964A Withdrawn JP2009108048A (ja) 1995-11-02 2008-10-08 分子シャペロン産生を増強するのに有用なヒドロキシルアミン誘導体およびそれの調製

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008261964A Withdrawn JP2009108048A (ja) 1995-11-02 2008-10-08 分子シャペロン産生を増強するのに有用なヒドロキシルアミン誘導体およびそれの調製

Country Status (31)

Country Link
US (4) US6653326B1 (enExample)
EP (1) EP0801649B1 (enExample)
JP (2) JP4531865B2 (enExample)
KR (1) KR19980700976A (enExample)
CN (1) CN1152871C (enExample)
AT (1) ATE221880T1 (enExample)
AU (1) AU720195B2 (enExample)
BG (1) BG63944B1 (enExample)
BR (1) BR9607565B1 (enExample)
CA (1) CA2209167C (enExample)
CZ (1) CZ295562B6 (enExample)
DE (1) DE69622840T2 (enExample)
DK (1) DK0801649T3 (enExample)
EE (1) EE04239B1 (enExample)
ES (1) ES2176502T3 (enExample)
HR (1) HRP960508B1 (enExample)
HU (1) HU222994B1 (enExample)
IL (1) IL121126A (enExample)
MX (1) MX9704988A (enExample)
NO (1) NO321140B1 (enExample)
NZ (1) NZ320523A (enExample)
PL (1) PL195634B1 (enExample)
PT (1) PT801649E (enExample)
RS (1) RS49981B (enExample)
RU (1) RU2206320C2 (enExample)
SI (1) SI0801649T1 (enExample)
SK (1) SK284823B6 (enExample)
TR (1) TR199700574T1 (enExample)
UA (1) UA61050C2 (enExample)
WO (1) WO1997016439A1 (enExample)
ZA (1) ZA969249B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
UA64716C2 (en) * 1996-08-09 2004-03-15 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
WO2000007580A2 (en) * 1998-08-03 2000-02-17 N-Gene Kutató Kft. Pharmaceutical compositions against autoimmune diseases
HU226617B1 (en) * 1998-12-14 2009-04-28 Cytrx Corp Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
FR2792832B1 (fr) * 1999-04-28 2002-05-10 Codif Internat Sa Procede de protection de la peau pour la prevenir de son vieillissement cellulaire
HUP0001583A2 (hu) * 2000-04-18 2002-11-28 BIOREX Kutató és Fejlesztő Rt. Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
WO2003000861A2 (en) * 2001-06-22 2003-01-03 The Regents Of The University Of California Eukaryotic genes involved in adult lifespan regulation
HUP0105205A2 (hu) * 2001-11-29 2003-08-28 BIOREX Kutató és Fejlesztő Rt. Metformint és egy hidroxilaminszármazékot tartalmazó, gyógyászati készítmény
RU2320330C2 (ru) * 2002-01-11 2008-03-27 СиУайТиАрЭкс КОРПОРЕЙШН Производные карбоксамидина и их использование при лечении заболеваний сосудов
BRPI0408802B8 (pt) * 2003-03-27 2021-07-27 Childrens Hospital Med Ct método para a detecção de uma lesão de célula tubular renal isquêmica e método para identificar a extensão desta lesão
HUP0303584A3 (en) * 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
AU2005232159B2 (en) * 2004-04-12 2008-10-16 Torrent Pharmaceuticals Ltd. 2-propene-1-ones as HSP 70 inducers
US7786093B2 (en) * 2004-07-07 2010-08-31 Health Wellness Foods Corporation Antistress agent
FR2880022B1 (fr) * 2004-12-24 2007-08-24 Mayoly Spindler Soc Par Action Nouveaux derives de la n-hydroxy-n'-phenyluree et de la n-hydroxy-n'-phenylthiouree et leur utilisation comme inhibiteurs de la synthese de la melanine
WO2008039514A1 (en) * 2006-09-26 2008-04-03 Cytrx Corporation Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
JP2010511622A (ja) * 2006-12-01 2010-04-15 シトルックス コーポレイション 発作の回復
TW200901958A (en) * 2007-05-04 2009-01-16 Cytrx Corp Diabetic wound healing
RU2010102899A (ru) * 2007-06-29 2011-08-10 Торрент Фармасьютикалз Лтд. (In) Новые замещенные пиперидоны в качестве индукторов hsp
PL2659904T3 (pl) 2008-06-26 2016-01-29 Orphazyme Aps Zastosowanie Hsp70 jako regulatora aktywności enzymatycznej
KR101645937B1 (ko) * 2008-11-11 2016-08-08 (주)아모레퍼시픽 육음외사에 의한 피부 변화를 정량하는 방법 및 이를 이용한 피부 개선 물질의 스크리닝 방법
BRPI0919867A2 (pt) * 2008-11-18 2015-12-15 Santen Pharmaceutical Co Ltd agente terapeutico ou profilatico para uma doenca degenerativa coriorretiniana, e metodo profilatico ou terapeutico para uma doenca degenerativa coriorrentiniana
US20110123473A1 (en) * 2009-11-26 2011-05-26 Basf Se Use of highly-branched polycarbonates in cosmetic and dermatological formulations
DK2646044T3 (da) 2010-11-30 2019-11-25 Orphazyme As Metoder til at øge den intracellulære aktivitet af Hsp70
KR101275264B1 (ko) 2011-08-24 2013-06-17 포항공과대학교 산학협력단 샤프로닌 단백질의 조절 물질 탐색 방법
HUP1100534A2 (en) 2011-09-26 2013-04-29 Balazs Dr Hazay Pharmaceutical composition for the treatment of muscle atrophy
HUP1100535A2 (en) 2011-09-26 2013-04-29 Bracelia Invest Ltd Pharmaceutical composition for enhancement of stem cell treatment
RU2495928C2 (ru) * 2012-01-30 2013-10-20 Сергей Юрьевич Лешков Средство для стимуляции синтеза белков теплового шока hsp 70 в клетках человека и животных; косметическое средство для стимуляции репаративных процессов; косметическое средство для снижения побочных эффектов агрессивных косметологических процедур; биологически активная добавка; пищевой продукт; способ снижения побочных эффектов агрессивных косметологических процедур
KR20250069686A (ko) 2014-09-15 2025-05-19 제브라 덴마크 에이/에스 아리모클로몰 제제
US10898476B2 (en) 2016-04-13 2021-01-26 Orphazyme A/S Heat shock proteins and cholesterol homeostasis
LT3448382T (lt) 2016-04-29 2021-04-12 Orphazyme A/S Arimoklomolis, skirtas su gliukocerebrozidaze susijusiems sutrikimams gydyti
WO2018215597A1 (en) 2017-05-24 2018-11-29 Orphazyme A/S Heat shock protein inducers and frontotemporal disorders
CN108314630B (zh) * 2018-02-08 2020-11-06 广西民族大学 一种肟醚类衍生物及其制备方法与应用
EP3803406A1 (en) 2018-05-28 2021-04-14 Orphazyme A/S Hsp70 protein levels in pbmc samples as biomarker for disease
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére
CN110048418B (zh) * 2019-05-08 2023-03-24 辽宁工程技术大学 一种基于细胞-组织算法的微电网经济调度方法及装置
IL299250A (en) 2020-06-24 2023-02-01 Kempharm Denmark As Arimoclomol for the treatment of Gaucher disease
CN112094878A (zh) * 2020-08-18 2020-12-18 周银根 一种二步酶提取香菇多糖的方法、香菇多糖提取物及其应用
US20230416224A1 (en) 2020-11-19 2023-12-28 Zevra Denmark A/S Processes for preparing arimoclomol citrate and intermediates thereof
MX2023007551A (es) 2020-12-24 2023-09-04 Zevra Denmark As Arimoclomol para el tratamiento de la enfermedad de niemann pick, tipo c, en pacientes con mutaciones de sentido erroneo de tipo reticulo endoplasmatico (er).
KR20240075869A (ko) * 2021-09-28 2024-05-29 제브라 덴마크 에이/에스 디옥사진 및 gba 관련 질환의 치료에서의 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177578B (en) * 1976-08-27 1981-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives
DE2651083A1 (de) 1976-11-09 1978-05-18 Hoechst Ag Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
HU207988B (en) 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HUT54347A (en) 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes
US5334600A (en) * 1991-07-30 1994-08-02 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
HU216830B (hu) 1992-07-21 1999-09-28 BIOREX Kutató és Fejlesztő Rt., N-[2-Hidroxi-3-amino-propoxi]-amidok és -imidátok, valamint dioxazinok, eljárás ezek előállítására, és a vegyületeket tartalmazó gyógyszerkészítmények
DK0758315T3 (da) * 1994-05-06 1999-05-25 Biorex Kutato Es Fejleszti Rt Hidtil ukendte hydroximsyrederivater, farmaceutiske sammensætninger indeholdende dem og fremgangsmåde til fremstilling af d
HU9502843D0 (en) * 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition

Similar Documents

Publication Publication Date Title
JP2000500228A5 (enExample)
JP2000500445A5 (enExample)
JP2001519643A5 (enExample)
JPH11510862A5 (enExample)
JP2000500440A5 (enExample)
JP2000500327A5 (enExample)
JP2000500145A5 (enExample)
JP2000500155A5 (enExample)
JP2000500406A5 (enExample)
JP2000500115A5 (enExample)
JP2000500322A5 (enExample)
JP2000500258A5 (enExample)
JP2000500342A5 (enExample)
JPH11514904A5 (enExample)
JP2000500192A5 (enExample)
JP2000500112A5 (enExample)
JPH10512590A5 (enExample)
JP2000500226A5 (enExample)
JP2000500051A5 (enExample)
JP2000500407A5 (enExample)
JP2000500166A5 (enExample)
JP2000514655A5 (enExample)
JP2000500346A5 (enExample)
JP2000500090A5 (enExample)
JP2000500257A5 (enExample)